Biopharmaceuticals
HIV/AIDS
News Release - December 18, 2015
Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare
Source: Bristol-Myers Squibb
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.